Stem Cell-Induced Inflammation in Cholesteatoma Is Inhibited by the TLR4 Antagonist LPS-RS
Cholesteatoma is a severe non-cancerous lesion of the middle ear characterized by massive inflammation, tissue destruction, and an abnormal growth of keratinized squamous epithelium. We recently demonstrated the presence of pathogenic stem cells within cholesteatoma tissue, unfortunately their poten...
Main Authors: | Matthias Schürmann, Johannes F. W. Greiner, Verena Volland-Thurn, Felix Oppel, Christian Kaltschmidt, Holger Sudhoff, Barbara Kaltschmidt |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-01-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/1/199 |
Similar Items
-
Chronic inflammation of middle ear cholesteatoma promotes its recurrence via a paracrine mechanism
by: Matthias Schürmann, et al.
Published: (2021-02-01) -
Dihydromyricetin attenuates inflammation through TLR4/NF-kappaB pathway
by: Jing Nianshui, et al.
Published: (2019-09-01) -
Review of potential medical treatments for middle ear cholesteatoma
by: Matthias Schürmann, et al.
Published: (2022-09-01) -
Cholesteatoma /
by: Smouha, Eric E., et al.
Published: (c201) -
The protective effects of saxagliptin against lipopolysaccharide (LPS)-induced inflammation and damage in human dental pulp cells
by: Xinxing Guo, et al.
Published: (2019-12-01)